{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:42:24Z","timestamp":1750308144385,"version":"3.41.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,18]]},"DOI":"10.7759\/cureus.86292","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T16:14:25Z","timestamp":1750263265000},"source":"Crossref","is-referenced-by-count":0,"title":["The Promising Role of Probiotics in the Prevention of Cardiovascular Risk Factors and Their Implication in Reducing Coronary Artery Disease: A Literature Review"],"prefix":"10.7759","author":[{"given":"Rahma","family":"Hashish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Agha Tabari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivling S","family":"Swami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alousious","family":"Kasagga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanuel Kefyalew","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maysaa N","family":"Amin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Kashmer","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081938","article-title":"Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease","volume":"10","author":"Fr\u0105k W","year":"2022","unstructured":"Fr\u0105k W, Wojtasi\u0144ska A, Lisi\u0144ska W, M\u0142ynarska E, Franczyk B, Rysz J. Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease. Biomedicines. 2022, 10:10.3390\/biomedicines10081938","journal-title":"Biomedicines"},{"key":"ref2","article-title":"Impact of diet on cardiovascular diseases: coronary artery disease part iii: micronutrients and supplements","volume":"5","author":"Agarwal SK","year":"2022","unstructured":"Agarwal SK. Impact of diet on cardiovascular diseases: coronary artery disease part iii: micronutrients and supplements. Asian J Cardiol Res. 2022, 5:13-29.","journal-title":"Asian J Cardiol Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2991\/jegh.k.201217.001","article-title":"Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review","volume":"11","author":"Ralapanawa U","year":"2021","unstructured":"Ralapanawa U, Sivakanesan R. Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health. 2021, 11:169-77. 10.2991\/jegh.k.201217.001","journal-title":"J Epidemiol Glob Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/efd2.120","article-title":"Probiotic or probiotics add supplement interferes with coronary heart disease: a meta\u2010analysis of randomized controlled trials","volume":"4","author":"Yang L","year":"2023","unstructured":"Yang L, Zhang J, Wang J, Zhao H, Xie X, Wu Q. Probiotic or probiotics add supplement interferes with coronary heart disease: a meta\u2010analysis of randomized controlled trials. eFood. 2023, 4:e120. 10.1002\/efd2.120","journal-title":"eFood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12020234","article-title":"The potential impact of probiotics on human health: an update on their health-promoting properties","volume":"12","author":"Maftei NM","year":"2024","unstructured":"Maftei NM, Raileanu CR, Balta AA, Ambrose L, Boev M, Marin DB, Lisa EL. The potential impact of probiotics on human health: an update on their health-promoting properties. Microorganisms. 2024, 12:10.3390\/microorganisms12020234","journal-title":"Microorganisms"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11092160","article-title":"The possible role of probiotic supplementation in inflammation: a narrative review","volume":"11","author":"Colletti A","year":"2023","unstructured":"Colletti A, Pellizzato M, Cicero AF. The possible role of probiotic supplementation in inflammation: a narrative review. Microorganisms. 2023, 11:10.3390\/microorganisms11092160","journal-title":"Microorganisms"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15245","article-title":"Characterization of gut microbiota in adults with coronary atherosclerosis","volume":"11","author":"Dong Y","year":"2023","unstructured":"Dong Y, Xu R, Chen X, et al.. Characterization of gut microbiota in adults with coronary atherosclerosis. PeerJ. 2023, 11:e15245. 10.7717\/peerj.15245","journal-title":"PeerJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13020256","article-title":"Gut microbiota and coronary artery disease: current therapeutic perspectives","volume":"13","author":"Katsimichas T","year":"2023","unstructured":"Katsimichas T, Theofilis P, Tsioufis K, Tousoulis D. Gut microbiota and coronary artery disease: current therapeutic perspectives. Metabolites. 2023, 13:10.3390\/metabo13020256","journal-title":"Metabolites"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1154888","article-title":"Meta-analysis of the effect of probiotics or synbiotics on the risk factors in patients with coronary artery disease","volume":"10","author":"Lei Y","year":"2023","unstructured":"Lei Y, Xu M, Huang N, Yuan Z. Meta-analysis of the effect of probiotics or synbiotics on the risk factors in patients with coronary artery disease. Front Cardiovasc Med. 2023, 10:1154888. 10.3389\/fcvm.2023.1154888","journal-title":"Front Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21542\/gcsp.2025.3","article-title":"The role of microbiome dysbiosis in cardiovascular disease: mechanisms and therapeutic implications","volume":"2025","author":"Abdulaal R","year":"2025","unstructured":"Abdulaal R, Tlaiss Y, Jammal F, et al.. The role of microbiome dysbiosis in cardiovascular disease: mechanisms and therapeutic implications. Glob Cardiol Sci Pract. 2025, 2025:e202503. 10.21542\/gcsp.2025.3","journal-title":"Glob Cardiol Sci Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082878","article-title":"Potential benefits of probiotics and prebiotics for coronary heart disease and stroke","volume":"13","author":"Wu H","year":"2021","unstructured":"Wu H, Chiou J. Potential benefits of probiotics and prebiotics for coronary heart disease and stroke. Nutrients. 2021, 13:10.3390\/nu13082878","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.3835","article-title":"Prebiotics plus probiotics may favorably impact on gut permeability, endocannabinoid receptors, and inflammatory biomarkers in patients with coronary artery diseases: a clinical trial","volume":"12","author":"Liu M","year":"2024","unstructured":"Liu M, Tandorost A, Moludi J, Dey P. Prebiotics plus probiotics may favorably impact on gut permeability, endocannabinoid receptors, and inflammatory biomarkers in patients with coronary artery diseases: a clinical trial. Food Sci Nutr. 2024, 12:1207-17. 10.1002\/fsn3.3835","journal-title":"Food Sci Nutr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/nu17010052","article-title":"Probiotics: a potential strategy for preventing and managing cardiovascular disease","volume":"17","author":"L\u00f3pez-Yerena A","year":"2024","unstructured":"L\u00f3pez-Yerena A, de Santisteban Villaplana V, Badimon L, Vilahur G, Padro T. Probiotics: a potential strategy for preventing and managing cardiovascular disease. Nutrients. 2024, 17:10.3390\/nu17010052","journal-title":"Nutrients"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/nu16172916","article-title":"Impact of Lactocaseibacillus (Lactobacillus) paracasei sup. paracasei TISTR 2593 probiotic supplementation on the gut microbiome of hypercholesterolemia patients: a randomized controlled trial","volume":"16","author":"Nuankham K","year":"2024","unstructured":"Nuankham K, Sitdhipol J, Chonpathompikunlert P, et al.. Impact of Lactocaseibacillus (Lactobacillus) paracasei sup. paracasei TISTR 2593 probiotic supplementation on the gut microbiome of hypercholesterolemia patients: a randomized controlled trial. Nutrients. 2024, 16:10.3390\/nu16172916","journal-title":"Nutrients"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001744","article-title":"Unlocking the gut-heart axis: exploring the role of gut microbiota in cardiovascular health and disease","volume":"86","author":"Shariff S","year":"2024","unstructured":"Shariff S, Kwan Su Huey A, Parag Soni N, et al.. Unlocking the gut-heart axis: exploring the role of gut microbiota in cardiovascular health and disease. Ann Med Surg (Lond). 2024, 86:2752-8. 10.1097\/MS9.0000000000001744","journal-title":"Ann Med Surg (Lond)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00100-22","article-title":"Bifidobacterium lactis Probio-M8 adjuvant treatment confers added benefits to patients with coronary artery disease via target modulation of the gut-heart\/-brain axes","volume":"7","author":"Sun B","year":"2022","unstructured":"Sun B, Ma T, Li Y, et al.. Bifidobacterium lactis Probio-M8 adjuvant treatment confers added benefits to patients with coronary artery disease via target modulation of the gut-heart\/-brain axes. mSystems. 2022, 7:e0010022. 10.1128\/msystems.00100-22","journal-title":"mSystems"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/nu15214663","article-title":"The effect of probiotic supplements on metabolic parameters of people with type 2 diabetes in Greece-a randomized, double-blind, placebo-controlled study","volume":"15","author":"Zikou E","year":"2023","unstructured":"Zikou E, Dovrolis N, Dimosthenopoulos C, Gazouli M, Makrilakis K. The effect of probiotic supplements on metabolic parameters of people with type 2 diabetes in Greece-a randomized, double-blind, placebo-controlled study. Nutrients. 2023, 15:10.3390\/nu15214663","journal-title":"Nutrients"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1495633","article-title":"Association of probiotic supplementation and cardiovascular risk profiles of patients with coronary artery disease-a cross-sectional analysis of the NHANES database between 1999-2019","volume":"12","author":"Palathinkara M","year":"2025","unstructured":"Palathinkara M, Aljadah M, Thorgerson A, Dawson AZ, Widlansky ME. Association of probiotic supplementation and cardiovascular risk profiles of patients with coronary artery disease-a cross-sectional analysis of the NHANES database between 1999-2019. Front Nutr. 2025, 12:1495633. 10.3389\/fnut.2025.1495633","journal-title":"Front Nutr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-021-00703-7","article-title":"Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial","volume":"20","author":"Moludi J","year":"2021","unstructured":"Moludi J, Kafil HS, Qaisar SA, Gholizadeh P, Alizadeh M, Vayghyan HJ. Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial. Nutr J. 2021, 20:47. 10.1186\/s12937-021-00703-7","journal-title":"Nutr J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6688450","article-title":"Probiotics as a complementary therapy for management of obesity: a systematic review","volume":"2021","author":"Shirvani-Rad S","year":"2021","unstructured":"Shirvani-Rad S, Tabatabaei-Malazy O, Mohseni S, et al.. Probiotics as a complementary therapy for management of obesity: a systematic review. Evid Based Complement Alternat Med. 2021, 2021:6688450. 10.1155\/2021\/6688450","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/nu16060815","article-title":"Effects of Bifidobacterium longum BB536 and Bifidobacterium breve MCC1274 on body composition in normal and overweight adults in randomized placebo-controlled study","volume":"16","author":"Sato S","year":"2024","unstructured":"Sato S, Arai S, Kato K, Yoshida K, Iwabuchi N, Sagami T, Tanaka M. Effects of Bifidobacterium longum BB536 and Bifidobacterium breve MCC1274 on body composition in normal and overweight adults in randomized placebo-controlled study. Nutrients. 2024, 16:10.3390\/nu16060815","journal-title":"Nutrients"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1440286","article-title":"Effect of probiotics on glycemic control and lipid profiles in patients with type 2 diabetes mellitus: a randomized, double blind, controlled trial","volume":"15","author":"Peng X","year":"2024","unstructured":"Peng X, Xian H, Ge N, et al.. Effect of probiotics on glycemic control and lipid profiles in patients with type 2 diabetes mellitus: a randomized, double blind, controlled trial. Front Endocrinol (Lausanne). 2024, 15:1440286. 10.3389\/fendo.2024.1440286","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2022.09.005","article-title":"Effects of probiotics supplementation on blood pressure: an umbrella meta-analysis of randomized controlled trials","volume":"33","author":"Zarezadeh M","year":"2023","unstructured":"Zarezadeh M, Musazadeh V, Ghalichi F, et al.. Effects of probiotics supplementation on blood pressure: an umbrella meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2023, 33:275-86. 10.1016\/j.numecd.2022.09.005","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12121165","article-title":"Human gut microbiota in coronary artery disease: a systematic review and meta-analysis","volume":"12","author":"Choroszy M","year":"2022","unstructured":"Choroszy M, Litwinowicz K, Bednarz R, et al.. Human gut microbiota in coronary artery disease: a systematic review and meta-analysis. Metabolites. 2022, 12:10.3390\/metabo12121165","journal-title":"Metabolites"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-024-00356-2","article-title":"Assessment of the causal relationship between gut microbiota and cardiovascular diseases: a bidirectional Mendelian randomization analysis","volume":"17","author":"Dai XC","year":"2024","unstructured":"Dai XC, Yu Y, Zhou SY, Yu S, Xiang MX, Ma H. Assessment of the causal relationship between gut microbiota and cardiovascular diseases: a bidirectional Mendelian randomization analysis. BioData Min. 2024, 17:6. 10.1186\/s13040-024-00356-2","journal-title":"BioData Min"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.693412","article-title":"Therapeutic and improving function of Lactobacilli in the prevention and treatment of cardiovascular-related diseases: a novel perspective from gut microbiota","volume":"8","author":"Zhao X","year":"2021","unstructured":"Zhao X, Zhong X, Liu X, Wang X, Gao X. Therapeutic and improving function of Lactobacilli in the prevention and treatment of cardiovascular-related diseases: a novel perspective from gut microbiota. Front Nutr. 2021, 8:693412. 10.3389\/fnut.2021.693412","journal-title":"Front Nutr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-023-00448-7","article-title":"The therapeutic value of bifidobacteria in cardiovascular disease","volume":"9","author":"Tang J","year":"2023","unstructured":"Tang J, Wei Y, Pi C, et al.. The therapeutic value of bifidobacteria in cardiovascular disease. NPJ Biofilms Microbiomes. 2023, 9:82. 10.1038\/s41522-023-00448-7","journal-title":"NPJ Biofilms Microbiomes"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1279996","article-title":"Evaluation of cholesterol transformation abilities and probiotic properties of Bacteroides dorei YGMCC0564","volume":"14","author":"He Z","year":"2023","unstructured":"He Z, Wang T, Zhang S, et al.. Evaluation of cholesterol transformation abilities and probiotic properties of Bacteroides dorei YGMCC0564. Front Microbiol. 2023, 14:1279996. 10.3389\/fmicb.2023.1279996","journal-title":"Front Microbiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-025-01104-w","article-title":"Association of the use of nonfood prebiotics, probiotics, and synbiotics with total and cause-specific mortality: a prospective cohort study","volume":"24","author":"Zheng L","year":"2025","unstructured":"Zheng L, Zhang J, Yang J, et al.. Association of the use of nonfood prebiotics, probiotics, and synbiotics with total and cause-specific mortality: a prospective cohort study. Nutr J. 2025, 24:45. 10.1186\/s12937-025-01104-w","journal-title":"Nutr J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/nu17050923","article-title":"Milk exosome-based delivery system for probiotic encapsulation that enhances the gastrointestinal resistance and adhesion of probiotics","volume":"17","author":"Hao L","year":"2025","unstructured":"Hao L, Liu Y, Szeto IM, Hao H, Zhang T, Liu T, Yi H. Milk exosome-based delivery system for probiotic encapsulation that enhances the gastrointestinal resistance and adhesion of probiotics. Nutrients. 2025, 17:10.3390\/nu17050923","journal-title":"Nutrients"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32465","article-title":"Role of gut microbiome in cardiovascular events: a systematic review","volume":"14","author":"Mansuri NM","year":"2022","unstructured":"Mansuri NM, Mann NK, Rizwan S, et al.. Role of gut microbiome in cardiovascular events: a systematic review. Cureus. 2022, 14:e32465. 10.7759\/cureus.32465","journal-title":"Cureus"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.21089\/njhs.62.0075","article-title":"Role of the gut microbiome in the pathophysiology and treatment of type 2 diabetes mellitus: a mini review","volume":"25","author":"Zainab A","year":"2022","unstructured":"Zainab A, Mago A, Mehmood A, Riad M, Sonavane SR. Role of the gut microbiome in the pathophysiology and treatment of type 2 diabetes mellitus: a mini review. Nat J Health Sci. 2022, 25:75-9. 10.21089\/njhs.62.0075","journal-title":"Nat J Health Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/life14111484","article-title":"Impact of multistrain probiotic supplementation on glycemic control in type 2 diabetes mellitus-randomized controlled trial","volume":"14","author":"Chaithanya V","year":"2024","unstructured":"Chaithanya V, Kumar J, Vajravelu Leela K, Ram M, Thulukanam J. Impact of multistrain probiotic supplementation on glycemic control in type 2 diabetes mellitus-randomized controlled trial. Life (Basel). 2024, 14:10.3390\/life14111484","journal-title":"Life (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1220877","article-title":"Probiotics: functional food ingredients with the potential to reduce hypertension","volume":"13","author":"Chen Z","year":"2023","unstructured":"Chen Z, Liang W, Liang J, et al.. Probiotics: functional food ingredients with the potential to reduce hypertension. Front Cell Infect Microbiol. 2023, 13:1220877. 10.3389\/fcimb.2023.1220877","journal-title":"Front Cell Infect Microbiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/nu16234079","article-title":"Gut microbiota and gut-brain axis in hypertension: implications for kidney and cardiovascular health-a narrative review","volume":"16","author":"M\u0142ynarska E","year":"2024","unstructured":"M\u0142ynarska E, Wasiak J, Gajewska A, et al.. Gut microbiota and gut-brain axis in hypertension: implications for kidney and cardiovascular health-a narrative review. Nutrients. 2024, 16:10.3390\/nu16234079","journal-title":"Nutrients"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111334","article-title":"Link between microbiota and hypertension: focus on LPS\/TLR4 pathway in endothelial dysfunction and vascular inflammation, and therapeutic implication of probiotics","volume":"137","author":"Grylls A","year":"2021","unstructured":"Grylls A, Seidler K, Neil J. Link between microbiota and hypertension: focus on LPS\/TLR4 pathway in endothelial dysfunction and vascular inflammation, and therapeutic implication of probiotics. Biomed Pharmacother. 2021, 137:111334. 10.1016\/j.biopha.2021.111334","journal-title":"Biomed Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/374117-the-promising-role-of-probiotics-in-the-prevention-of-cardiovascular-risk-factors-and-their-implication-in-reducing-coronary-artery-disease-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T16:14:25Z","timestamp":1750263265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/374117-the-promising-role-of-probiotics-in-the-prevention-of-cardiovascular-risk-factors-and-their-implication-in-reducing-coronary-artery-disease-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.86292","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,18]]}}}